http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2012144499-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cd727aa2b4e6c347aadd94971881d671 |
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q19-00 |
| filingDate | 2011-01-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_961a1c9c539a02efa198412e0fa7acb0 |
| publicationDate | 2012-08-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2012144499-A |
| titleOfInvention | Extracellular matrix component production inhibitor |
| abstract | A novel agent having an action of suppressing production of extracellular matrix components, promotion of matrix-degrading enzyme production, and / or inhibition of fibroblast proliferation, which is a purified collagenase derived from adrenal lipid steroids and the aforementioned clostridial To develop a stable and safe agent without the side effects. The present invention relates to an extracellular matrix component production inhibitor and a matrix-degrading enzyme production promotion comprising one or more compounds selected from the group consisting of palmitic acid and derivatives and / or salts thereof. An agent and / or a fibroblast growth inhibitor is provided. [Selection figure] None |
| priorityDate | 2011-01-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 52.